MarketInOut Stock Screener Log In | Sign Up

Nutriband Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 09/30/2026
Nutriband Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization6.69 mln
Float5.28 mln
Earnings Date12/11/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-5.85
Highly reliable

Relative Strength

1 / 100
Severely lagging

Debt / Equity

0.04
Debt-free

Pre-Tax Margin

-430%
Severely loss-making

ROE

-102
Deeply negative

Business Description

Nutriband Inc. is a Florida-based pharmaceutical company focused on developing skin patch drug delivery systems designed to reduce the risk of opioid abuse. Its main product, AVERSA fentanyl, is a pain-relief patch built to deter misuse while still giving patients steady, long-term access to medication. The company is also working on additional patch-based treatments and partners with Kindeva Drug Delivery to support its development and production efforts.

Key Fundamentals

EPS-0.50
ROE-102
RPS0.13
ROIC-254
ROA-88.52
Interest Cover-339
EBITDA, mln-6.90
EV / EBITDA-9.90
Revenue, mln1.62

Quote Details

Last 0.55
Change -1.18 (-68.21%)
Open 1.71
Volume 46,058
Turnover 25,332
Average Volume 11,423

Financial Ratios

Pre-Tax Profit Margin-430
Leverage Ratio1.18
Current Ratio4.21
Price / Book1.26
Debt / Equity0.04
Price / Sales19.57

Financial Strength

Altman Z-Score48.7
Piotroski F-Score 3 / 9
Beneish M-Score-5.85

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -25.77% 2 / 100   
1 Month -21.43% 9 / 100   
2 Months -65.62% 3 / 100   
6 Months -63.82% 6 / 100   
1 Year -65.62% 11 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog